Hansoh Pharmaceutical Group Co (HKSE:03692) Margin of Safety % (DCF Earnings Based): N/A (As of Jul. 02, 2026)


HKSE:03692 Hansoh Pharmaceutical Group Co Ltd HKSE:03692
94 GF Score
Price HK$31.52
GF Value HK$26.39
Valuation Modestly Overvalued
View Full Analysis

What is Hansoh Pharmaceutical Group Co Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Hansoh Pharmaceutical Group Co's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

HKSE:03692 vs ZTS, UTHR: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hansoh Pharmaceutical Group Co's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hansoh Pharmaceutical Group Co Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hansoh Pharmaceutical Group Co's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Hansoh Pharmaceutical Group Co's Margin of Safety % (DCF Earnings Based) falls into.


HKSE:03692
94GF Score
Hansoh Pharmaceutical Group Co Ltd HKSE:03692
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Hansoh Pharmaceutical Group Co (HKSE:03692) Overvalued in 2026?

Based on GuruFocus' analysis, Hansoh Pharmaceutical Group Co stock appears to be overvalued. The current stock price of HK$31.52 is trading 19.4% above its estimated GF Value™ of HK$26.39. GuruFocus considers Hansoh Pharmaceutical Group Co to be Modestly Overvalued.

Key valuation signals for HKSE:03692:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: HK$26.39 vs. price of HK$31.52 (19.4% above fair value)
  • GF Score™: 94/100

No single metric tells the full story. See the HKSE:03692 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hansoh Pharmaceutical Group Co Business Description

Address No. 287 Xiangke Road, Pudong New Area, Shanghai, CHN
Hansoh Pharmaceutical Group Co Ltd is an investment holding company. The company were principally engaged in the research and development, production and sale of a series of pharmaceutical products in the People's Republic of China. It focuses on disease therapeutic areas such as oncology, anti-infectives, CNS, metabolism and immunology. The majority of Group's revenue was generated from the sale of pharmaceutical products in Chinese mainland.
94GF Score

Get the complete analysis for HKSE:03692

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$31.52
Price
HK$26.39
GF Value